NO20002279D0 - Sammensetninger av lipidsenkende midler - Google Patents

Sammensetninger av lipidsenkende midler

Info

Publication number
NO20002279D0
NO20002279D0 NO20002279A NO20002279A NO20002279D0 NO 20002279 D0 NO20002279 D0 NO 20002279D0 NO 20002279 A NO20002279 A NO 20002279A NO 20002279 A NO20002279 A NO 20002279A NO 20002279 D0 NO20002279 D0 NO 20002279D0
Authority
NO
Norway
Prior art keywords
lipid
compositions
lowering agents
lowering
agents
Prior art date
Application number
NO20002279A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002279L (no
Inventor
Lieven Baert
Geert Verreck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20002279L publication Critical patent/NO20002279L/no
Publication of NO20002279D0 publication Critical patent/NO20002279D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20002279A 1997-11-03 2000-04-28 Sammensetninger av lipidsenkende midler NO20002279D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203407 1997-11-03
PCT/EP1998/006998 WO1999022738A1 (en) 1997-11-03 1998-10-27 Compositions of lipid lowering agents

Publications (2)

Publication Number Publication Date
NO20002279L NO20002279L (no) 2000-04-28
NO20002279D0 true NO20002279D0 (no) 2000-04-28

Family

ID=8228898

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002279A NO20002279D0 (no) 1997-11-03 2000-04-28 Sammensetninger av lipidsenkende midler

Country Status (20)

Country Link
US (1) US6342245B1 (de)
EP (1) EP1028730B1 (de)
JP (1) JP2001521899A (de)
KR (2) KR20010023661A (de)
CN (1) CN1278175A (de)
AR (1) AR013739A1 (de)
AT (1) ATE216238T1 (de)
AU (1) AU746890B2 (de)
BG (1) BG104338A (de)
BR (1) BR9814109A (de)
CA (1) CA2307097A1 (de)
DE (1) DE69804994D1 (de)
EE (1) EE200000186A (de)
HU (1) HUP0004139A3 (de)
NO (1) NO20002279D0 (de)
NZ (1) NZ503413A (de)
PL (1) PL340305A1 (de)
SK (1) SK5972000A3 (de)
WO (1) WO1999022738A1 (de)
ZA (1) ZA989997B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03011784A (es) 2001-06-22 2004-04-02 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros.
US20030059487A1 (en) * 2001-09-21 2003-03-27 Niazi Sarfaraz K. Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals
US20040220240A1 (en) * 2001-11-28 2004-11-04 Pellegrini Cara A. Method of increasing the extent of absorption of tizanidine
US6455557B1 (en) * 2001-11-28 2002-09-24 Elan Pharmaceuticals, Inc. Method of reducing somnolence in patients treated with tizanidine
MXPA06003452A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente.
DE602004032149D1 (de) * 2003-09-26 2011-05-19 Alza Corp Oros-push-stick für die kontrollierte abgabe von wirkstoffen
EP2184058B1 (de) 2003-09-26 2012-02-08 ALZA Corporation Arzneistoffcoating mit hohem Wirkstoffanteil sowie Methoden zu dessen Herstellung
NZ546182A (en) * 2003-09-26 2009-08-28 Alza Corp Controlled release formulations of opioid and nonopioid analgesics such as hydrocodone and acetaminophen
CN101664411A (zh) 2003-11-14 2010-03-10 味之素株式会社 苯丙氨酸衍生物的固体分散体或固体分散体医药制剂
JP2008504229A (ja) * 2004-04-09 2008-02-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 過剰体重および肥満症患者のための間欠的投薬レジメン
WO2005117834A1 (en) * 2004-05-27 2005-12-15 Janssen Pharmaceutica N.V. Solid dispersions of a basic drug compound and a polymer containing acidic groups
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
KR100582347B1 (ko) * 2004-12-30 2006-05-22 한미약품 주식회사 3-하이드록시-3-메틸글루타릴 조효소 a 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
JP2008542255A (ja) * 2005-05-27 2008-11-27 ファイザー・プロダクツ・インク 肥満症の治療または体重減量の維持のためのカンナビノイド−1受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用
ES2576633T3 (es) * 2005-08-08 2016-07-08 Abbvie Deutschland Gmbh & Co Kg Formas de dosificación con una biodisponibilidad mejorada
EP1938804A1 (de) * 2006-12-22 2008-07-02 Novartis AG Pharmazeutische Zubereitung enthaltend Neurokinin Antagonist
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
WO2010143199A1 (en) 2009-06-11 2010-12-16 Suven Nishtaa Pharma Private Limited Solid lipid dispersion for aqueous solubility enhancement of poorly water soluble drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521186A (en) * 1994-10-27 1996-05-28 Janssen Pharmaceutica N.V. Apolipoprotein-β synthesis inhibitors
RO118715B1 (ro) * 1994-10-27 2003-09-30 Janssen Pharmaceutica Nv Inhibitori ai sintezei apolipoproteinei-b

Also Published As

Publication number Publication date
CN1278175A (zh) 2000-12-27
BG104338A (en) 2000-12-29
AU1157699A (en) 1999-05-24
SK5972000A3 (en) 2000-12-11
AU746890B2 (en) 2002-05-02
NO20002279L (no) 2000-04-28
AR013739A1 (es) 2001-01-10
BR9814109A (pt) 2000-10-03
JP2001521899A (ja) 2001-11-13
ATE216238T1 (de) 2002-05-15
KR20010023661A (ko) 2001-03-26
HUP0004139A2 (hu) 2002-02-28
US6342245B1 (en) 2002-01-29
PL340305A1 (en) 2001-01-29
NZ503413A (en) 2001-06-29
EP1028730A1 (de) 2000-08-23
HUP0004139A3 (en) 2002-03-28
KR20010023729A (ko) 2001-03-26
CA2307097A1 (en) 1999-05-14
WO1999022738A1 (en) 1999-05-14
DE69804994D1 (de) 2002-05-23
EE200000186A (et) 2001-04-16
ZA989997B (en) 2000-05-02
EP1028730B1 (de) 2002-04-17

Similar Documents

Publication Publication Date Title
ID22931A (id) Komposisi-komposisi herbisidal
ID22970A (id) Komposisi perekat
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
DK1298194T3 (da) Staniolholdige sammensætninger
DE69811436D1 (de) Verbesserte Verarbeitbarkeit von Silica-gefüllten Kautschukzusammensetzungen
DE69819522D1 (de) Waschmittelzusammensetzungen
PT945132E (pt) Composicao de ibuprofeno
FI974241A7 (fi) BPM-15 -koostumukset
ID16251A (id) Komposisi-komposisi pembasmi kuman
DE69816227D1 (de) Klebstoffzusammensetzungen
PT1014987E (pt) Composicoes orais de levosimendano
PT907364E (pt) Composicao farmaceutica de libertacao sustida
NO20002279D0 (no) Sammensetninger av lipidsenkende midler
DE69826138D1 (de) Parfümzusammensetzung
MA24799A1 (fr) Compostions detergentes
ID22764A (id) Komposisi pembersih abrasif-semprot
PT1028718E (pt) Formulacao de libertacao prolongada
DE69617029D1 (de) Organoton-zusammensetzungen
NO981568D0 (no) Randtennings-tennsatssammensetninger
DE69806930D1 (de) Waschmittelzusammensetzungen
ID24374A (id) Komposisi-komposisi parenteral alatrofloksasin
ID25650A (id) Komposisi-komposisi sampo
NO993460D0 (no) Paroxetine-preparater
ID18832A (id) Komposisi insektisida
ID20699A (id) Komposisi pelembut kain

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application